National News Desk

Homeland Security Act Restricts Thimerosal Lawsuits

Posted by Staff Writer
Monday, December 09, 2002 12:00 AM EST
Category: Major Medical
Tags: Defective Drugs, Vaccines, Thimerosal

A provision added to the Homeland Security Act just days before Congress approved the legislation last month restricts families from filing lawsuits against the maker of Thimerosal, a mercury-based vaccine preservative linked to the development of autism. Instead, before they can take their claims to civil court, families are now required to file claims under the National Vaccine Injury Compensation Program, which limits damages for pain, suffering and death to $250,000. In addition, the Justice Department has filed a request to restrict in subsequent civil court cases the use of any information gathered or revealed during a compensation program proceeding.

Thimerosal, which was made by pharmaceutical manufacturer Eli Lilly and Co. until the 1980s, is 50 percent mercury and may be responsible for exposing some children to mercury levels significantly higher than Federal guidelines recommend.


No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes